Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
PMID: 41887313 Nanoscale Targeting glutamine metabolism combined with a nanoradioenhancer in radioresistant hepatocellular carcinoma
Dr Rossing has received consulting and/or speaking fees (to his institution) from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, Novo Nordisk, and Sanofi
Patients should maintain records of pharmacy dispensing dates and opening dates
The first promotes albumin binding, which slows renal clearance
Provides essential and non-essential amino acids for overall health
US$ 23.50
US$ 24.87
US$ 20.26
US$ 24.94
US$ 28.03
